Tiziana Life Sciences is trading 6.25% down at $1.05, with no clear company-specific catalyst identified for August 19, 2026.
- Latest listed disclosures are insider share purchases dated August 4 and August 6, rather than a new announcement today.
- The decline comes despite biotechnology strength and modestly higher major indexes.
- Further company news or trading-volume data may clarify the unexplained move.